Vysov D (Vildagliptin/Dapagliflozin)
| Active Ingredient | Vildagliptin/Dapagliflozin |
|---|---|
| Indication: | Type 2 diabetes |
| Manufacturer: | Cipla Limited |
| Strength | 100mg/5mg |
| Packaging | 10 Tablets in 1 Strip |
Vysov-D is a combination medication containing Vildagliptin and Dapagliflozin, designed for the effective management of type 2 diabetes mellitus. This dual-action formula works through two complementary mechanisms:
Vildagliptin (DPP-4 inhibitor): Increases insulin secretion and decreases glucagon release in a glucose-dependent manner.
Dapagliflozin (SGLT2 inhibitor): Helps the kidneys remove excess glucose through urine.
Together, they improve blood sugar control, reduce HbA1c levels, and may aid in weight management without causing hypoglycemia when used alone.
✅ Note: Vysov D is to be taken under medical supervision and as part of a complete diabetes care plan including diet and exercise.









There are no reviews yet.